Coronavirus survivor gets whopping $1.1 million hospital bill in US

By: |
Published: June 14, 2020 8:41 PM

Michael Flor was so sick from COVID-19 that his wife and kids called him to say good-bye. But he managed to pull through while being treated at Swedish Medical Center in Issaquah.

The total tab for his bout with the coronavirus: USD 1.1 million. Michael Flor battled with coronavirus for 62 days at Swedish Issaquah, making him the longest coronavirus patient at the hospital. (Reuters – representational image)

A 70-year-old man in the US, who nearly died from the coronavirus, received another shock after he was given a whopping USD 1.1 million (over Rs 8.14 crore) bill for his medical expenses, according to a media report. Michael Flor was so sick from COVID-19 that his wife and kids called him to say good-bye. But he managed to pull through while being treated at Swedish Medical Center in Issaquah, the Seattle Times reported.

“I opened it and said holy [bleep]!’ Flor says. The total tab for his bout with the coronavirus: USD 1.1 million. Michael Flor battled with coronavirus for 62 days at Swedish Issaquah, making him the longest coronavirus patient at the hospital.

Flor has a Medicare Advantage insurance policy that normally covers all charges after the roughly USD 6,000 deductible, the paper reported. Special financial regulations enacted by Congress for COVID-19 patients, however, might keep Flor from paying one red cent, the Seattle Times said.

Flor said he was surprised by his own reaction to beating the coronavirus. “I feel guilty about surviving,” he said. “There’s a sense of, why me?’ Why did I deserve all this? Looking at the incredible cost of it all definitely adds to that survivor’s guilt.

Get live Stock Prices from BSE, NSE, US Market and latest NAV, portfolio of Mutual Funds, calculate your tax by Income Tax Calculator, know market’s Top Gainers, Top Losers & Best Equity Funds. Like us on Facebook and follow us on Twitter.

Financial Express is now on Telegram. Click here to join our channel and stay updated with the latest Biz news and updates.

Next Stories
1COVID-19 cure: Gilead says additional data on antiviral remdesivir shows improved clinical recovery
2Pfizer, BioNTech’s Covid-19 vaccine expected to be ready for approval by year end: Report
3Season of two viruses? Scientists worried that dengue outbreak may aggravate COVID-19 crisis